SMARCA4 inactivation was shown to promote NSCLC aggressiveness by altering chromatin organization [30], and the reduced expression of SMARCA4 contributes to poor outcomes in lung cancer [26, 38, 39]. The gene discussed is SMARCA4; the disease is lung cancer.